Cargando…
Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
BACKGROUND: The prognostic significance of tumoral programmed death-ligand 2 (PD-L2) expression in urothelial bladder cancer (UBCs) is under-investigated , although it can potentially to become a regulatory agent of cancer immunity. In the search for supporting biomarkers, the neutrophil-to-lymphocy...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685214/ https://www.ncbi.nlm.nih.gov/pubmed/37642053 http://dx.doi.org/10.31557/APJCP.2023.24.8.2673 |
_version_ | 1785151580416245760 |
---|---|
author | Hendri, Ahmad Zulfan Soerohardjo, Indrawarman Heriyanto, Didik Setyo Khalilullah, Said Alfin Dany, Yurisal Akhmad Danurdoro, Aria |
author_facet | Hendri, Ahmad Zulfan Soerohardjo, Indrawarman Heriyanto, Didik Setyo Khalilullah, Said Alfin Dany, Yurisal Akhmad Danurdoro, Aria |
author_sort | Hendri, Ahmad Zulfan |
collection | PubMed |
description | BACKGROUND: The prognostic significance of tumoral programmed death-ligand 2 (PD-L2) expression in urothelial bladder cancer (UBCs) is under-investigated , although it can potentially to become a regulatory agent of cancer immunity. In the search for supporting biomarkers, the neutrophil-to-lymphocyte ratio (NLR) as a readily available surrogate marker of immune status has been associated with clinical outcomes and other prognostic factors in various types of cancer. Here we evaluate the prognostic ability of baseline NLR in addition to PD-L2 expression in bladder cancer. METHODS: We used a retrospective cohort of UBCs patients from the authors’ institutions. We classified patients according to their PD-L2 and NLR levels. We associated the prognostic outcome of each group with disease-free survival (DFS) and overall survival (OS). RESULTS: Thirty patients had a tumor with positive PD-L2 expression. We found no significant correlation between PD-L2 expression and NLR. PD-L2 status failed to provide a significant prognostic impact (disease-free survival [DFS] and overall survival [OS] rate at 5 years, 42.85% in PD-L2-high versus 65.75% in PD-L2-low patients; p = 0.057, 42.85% in PD-L2-high patients versus 62.5% in PD-L2-low patients; p = 0.112, respectively). NLR status also failed to exhibit a significant prognostic impact (DFS and OS rate at 5 years, 44.44% in PD-L2-high versus 66.66% in PD-L2-low patients; p = 0.232, 55.55% in PD-L2-high versus 71.43% in PD-L2-low patients; P = 0.894, respectively). When PD-L2 status and NLR status were combined, the NLR-low and PD-L2-low were significant factors to predict a favorable disease-free survival (hazard ratio, 4.525 [95% confidence interval, 1.020 to 20.080]; P = 0.047. However, the multivariate analysis failed to show it as an independent factor. CONCLUSION: These findings suggest that the prognostic impact of PD-L2 expression could be affected by the NLR status. |
format | Online Article Text |
id | pubmed-10685214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-106852142023-11-30 Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder Hendri, Ahmad Zulfan Soerohardjo, Indrawarman Heriyanto, Didik Setyo Khalilullah, Said Alfin Dany, Yurisal Akhmad Danurdoro, Aria Asian Pac J Cancer Prev Research Article BACKGROUND: The prognostic significance of tumoral programmed death-ligand 2 (PD-L2) expression in urothelial bladder cancer (UBCs) is under-investigated , although it can potentially to become a regulatory agent of cancer immunity. In the search for supporting biomarkers, the neutrophil-to-lymphocyte ratio (NLR) as a readily available surrogate marker of immune status has been associated with clinical outcomes and other prognostic factors in various types of cancer. Here we evaluate the prognostic ability of baseline NLR in addition to PD-L2 expression in bladder cancer. METHODS: We used a retrospective cohort of UBCs patients from the authors’ institutions. We classified patients according to their PD-L2 and NLR levels. We associated the prognostic outcome of each group with disease-free survival (DFS) and overall survival (OS). RESULTS: Thirty patients had a tumor with positive PD-L2 expression. We found no significant correlation between PD-L2 expression and NLR. PD-L2 status failed to provide a significant prognostic impact (disease-free survival [DFS] and overall survival [OS] rate at 5 years, 42.85% in PD-L2-high versus 65.75% in PD-L2-low patients; p = 0.057, 42.85% in PD-L2-high patients versus 62.5% in PD-L2-low patients; p = 0.112, respectively). NLR status also failed to exhibit a significant prognostic impact (DFS and OS rate at 5 years, 44.44% in PD-L2-high versus 66.66% in PD-L2-low patients; p = 0.232, 55.55% in PD-L2-high versus 71.43% in PD-L2-low patients; P = 0.894, respectively). When PD-L2 status and NLR status were combined, the NLR-low and PD-L2-low were significant factors to predict a favorable disease-free survival (hazard ratio, 4.525 [95% confidence interval, 1.020 to 20.080]; P = 0.047. However, the multivariate analysis failed to show it as an independent factor. CONCLUSION: These findings suggest that the prognostic impact of PD-L2 expression could be affected by the NLR status. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10685214/ /pubmed/37642053 http://dx.doi.org/10.31557/APJCP.2023.24.8.2673 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Research Article Hendri, Ahmad Zulfan Soerohardjo, Indrawarman Heriyanto, Didik Setyo Khalilullah, Said Alfin Dany, Yurisal Akhmad Danurdoro, Aria Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder |
title | Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder |
title_full | Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder |
title_fullStr | Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder |
title_full_unstemmed | Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder |
title_short | Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder |
title_sort | prognostic significance of pd-l2 expression in association with neutrophil-to-lymphocyte ratio in urothelial carcinoma of the bladder |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685214/ https://www.ncbi.nlm.nih.gov/pubmed/37642053 http://dx.doi.org/10.31557/APJCP.2023.24.8.2673 |
work_keys_str_mv | AT hendriahmadzulfan prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder AT soerohardjoindrawarman prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder AT heriyantodidiksetyo prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder AT khalilullahsaidalfin prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder AT danyyurisalakhmad prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder AT danurdoroaria prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder |